Marilyn B. Tavenner Sells 32,000 Shares of Select Medical Holdings Co. (NYSE:SEM) Stock

Select Medical Holdings Co. (NYSE:SEM) Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Select Medical Stock Up 3.7 %

NYSE SEM opened at $21.11 on Friday. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical Holdings Co. has a 52 week low of $20.00 and a 52 week high of $40.98. The stock has a market capitalization of $2.73 billion, a P/E ratio of 9.86, a price-to-earnings-growth ratio of 0.91 and a beta of 1.42. The stock has a fifty day moving average of $34.11 and a 200-day moving average of $34.71.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same period in the previous year, the business posted $0.46 EPS. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. On average, equities research analysts forecast that Select Medical Holdings Co. will post 2.16 EPS for the current year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s payout ratio is 23.36%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP lifted its stake in Select Medical by 2.2% in the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock valued at $157,728,000 after buying an additional 95,578 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Select Medical by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after purchasing an additional 46,880 shares in the last quarter. Principal Financial Group Inc. grew its position in shares of Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after purchasing an additional 147,032 shares during the period. Point72 Asset Management L.P. increased its stake in Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Select Medical by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after buying an additional 24,439 shares during the period. 89.48% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently commented on SEM. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Royal Bank of Canada boosted their price objective on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. StockNews.com lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday, November 21st. Finally, Bank of America assumed coverage on shares of Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target on the stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.